Rapid immuno-diagnosis of influenza A, B & SARS-CoV Single test for 3 parameters: antigen test of influenza A,B & SARS-CoV-2 Easy to use, Simple Procedure, Quick resulting and high Accuracy.
Production information:
1.Specimen: nasopharyngeal swab or Viral transport medium (VTM)
2.No Cross-reaction with 27 kinds of other respiratory viruses.
3.No interference with 23 kinds of interfering substances.
4.Limit of detection (LoD):1.89x10 HA units/mL for influenza A, 4.1 x 10 HA units/ mL for influenza B, 1.78x10 TCID/mL for SARS-CoV-2.
5.Detection of SARS-CoV-2 Varients: alpha,beta,gamma, delta, omicron & stealth omicron.
Product Details:
Number of Reactions(Preps)/Kit : 25 Test
Brand : GenBody
Sample Type : Nasal Swab
Storage Temperature : -2 to - 30 C
Cat. No : CVIFG040-1
Genbody Influenza/ Covid - 19 Ag Triple,
Rapid immuno-diagnosis of influenza A, B & SARS-CoV Single test for 3 parameters: antigen test of influenza A,B & SARS-CoV-2 Easy to use, Simple Procedure, Quick resulting and high Accuracy.
Production information:
1.Specimen: nasopharyngeal swab or Viral transport medium (VTM)
2.No Cross-reaction with 27 kinds of other respiratory viruses.
3.No interference with 23 kinds of interfering substances.
4.Limit of detection (LoD):1.89x10 HA units/mL for influenza A, 4.1 x 10 HA units/ mL for influenza B, 1.78x10 TCID/mL for SARS-CoV-2.
5.Detection of SARS-CoV-2 Varients: alpha,beta,gamma, delta, omicron & stealth omicron.
FAST: Results in under 2 minutes
ACCURATE: 99.9% specificity and 98.7% sensitivity
EASY TO USE: Convenient for testing at home
PAINLESS: Simple and painless saliva collection
RELIABLE: 24-Hour RT-PCR Confirmation (100% specific and 100% sensitive)
99.9% specificity.
Test specificity this high ensures that almost all the people who are not infected get a negative test result with the Sensiva React Rapid Covid-19 Testing Kit. Using a fast and accurate test such as this one is vital when we are trying to stop virus transmission and protect general health.
98.7% sensitivity
Test sensitivity refers to the percentage of infected people who get a positive test result. In our case that means that 98.7% of people with an infection get a positive test result.
How to use it?
Step 1 â?? Do the test
Sensiva React Rapid Test is a simple test that can be� easily done at home. It is convenient and� painless� since it requires you to collect a saliva sample instead of a nasal swab. How to do it? First, use the mobile application to scan the QR code to register. After that, collect a saliva sample and add it into the saliva hole in the reader device before adding the liquid solution. You will be able to interpret your� results in under 2 minutes. Watch a video with detailed instructions on how to do the test in the video below. Please follow the instructions carefully to obtain a valid test result.
Step 2 â?? Get RT-PCR confirmation in 24 hours
You can use the prepaid shipping label and send the saliva sample used for the rapid test to us. You will get an official PCR result (100% sensitivity and 100% specificity) in 24 hours. Our lab is certified under the Clinical Laboratory Improvement Amendments (CLIA), so you can rely on us to provide you with accurate and reliable test results.
Who is Sensiva React Rapid Covid-19 Test for?
Sensiva React Rapid Covid-19 Test is designed for patients with COVID-19 symptoms or those who are asymptomatic but suspected of having exposure. Its easy-to-follow instructions make it convenient for testing at home.
The kit contains:
(1) Specimen Tube
(1) Saliva Funnel
(1) Dropper
(1) Bio-hazard bag with absorbent pad
(1) Lateral flow device
(1) 5ml EZ-Tear Saline Solution
(1) 0.3ml EZ-Tear Buffer Solution
(1) Written Instruction Card
Offering Safecare3 Covid 19 antigen + A+B flue, 1:3 combo tests, single packed, self testing, 2 years self time from my warehouse in Vilnius, Lithuania.
5950 Influenza Covid 19 Ag Triple Suppliers
Short on time? Let Influenza Covid 19 Ag Triple sellers contact you.
Offering Alltest Covid 19 antigen + A+B flue, 1:3 combo tests, single packed, self testing, 2 years self time from my warehouse in Vilnius, Lithuania. Good price from authorised Alltest distributor.
Vannin Healthcare offers several effective COVID-19 tests:
SGTi-flex COVID-19 IgM/IgG (25 tests per kit)
STANDARD Q COVID-19 IgM/IgG Duo Test (40 tests per kit)
Anti-SARS-CoV-2 Rapid Test (50 tests per kit)
General Features
Can detect and differentiate between IgM and IgG antibodies
Convenient: no additional equipment necessary
Extremely fast: results in 10-15 minutes
Point-of-care testing
Allow rapid decision-making in high-stakes situations
Why our tests
Certified: CE-IVD marked, FDA-cleared, ISO 13485, Korea GMP-certified
Reliable: high clinical specificity and selectivity
Easy to interpret
Can detect antibodies even in asymptomatic patients
Vannin Healthcare Global offers various diagnostic and serology tests for identifying the presence of Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV-2). SARS-CoV-2 is the virus that causes COVID-19 which means that its presence could indicate that a person has been infected.
There are two types of tests currently used to determine the presence of the virus:
To find out whether antibodies are present in an obtained sample (whole blood, plasma, or serum), serology tests are used. The presence of antibodies could indicate a past infection. And depending on the type of the immunoglobulins present, it could also determine the approximate time when the infection occurred.
After fighting a coronavirus, our bodies are likely to produce two classes of antibodies: IgM and IgG. In the case of SARS-CoV-2, both IgM and IgG are most likely to occur simultaneously within two to three weeks after a person's been infected. For a firmer diagnosis, Vannin Healthcare Global offers serology tests that check for both IgM and IgG antibodies.
Can detect and differentiate between IgM and IgG antibodies
Differentiating between the antibodies is crucial when it comes to providing proper medical advice to your patients. The appearance of IgM antibodies is the initial response of the organism fighting to suppress the virus. These antibodies could indicate that the patient is still infectious, and advising patients to self-isolate is the appropriate course of action. IgG antibodies can be detected in the blood sample usually within7-10 days after the onset of infection. If a patient has IgG antibodies, and no IgM antibodies, they have developed a temporary immunity to COVID-19.
No additional equipment necessary
The test design makes it a perfect choice for remote areas without access to fully-equipped laboratories. Simply obtain a blood sample from a patient, and add 10�µl into the appropriate place on the testing cassette along with three drops (90µl) of the buffer. The results will appear in 10-15 minutes.
BinaxNOW COVID-19 Ag Card
For Rapid Detection of SARS-CoV-2 | FDA EUA | IVD Use | RX Only
The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct anterior nasal (nares) swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.
Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in anterior nasal (nares) swabs during the acute phase of infection.
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
Negative results should be treated as presumptive, do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.
The BinaxNOW COVID-19 Ag Card is intended for use by medical professionals or trained operators who are proficient in performing rapid lateral flow tests. BinaxNOW COVID-19 Ag Card is only for use under the Food and Drug Administration's EUA.
Kit Details
Test Card: 40 cards with test strips
Extraction Reagent: bottle containing 7.5 mL of extraction reagent
Nasal swabs: 40 sterile, single use specimen sampling swabs
Positive Control Swab: 1 each â??individually wrapped for single use
Negative Control Swab: 1 each â??individually wrapped for single use
Documentation: Product Insert, Procedure Card
Performance Data
The iNSTAXPLOR COVID-19 Ag is a rapid chromatographic immunoassay for the qualitative detection of antigens specific to SARS-CoV-2 in swab samples collected from a human nasopharynx.
SALIENT FEATURES
-Best suited for early detection of COVID â?? 19 infection from the onset of symptoms
-Point-of-care test / On the spot test
-Quick results in 15 to 30 mins
-ICMR validated and approved
-No Equipment required - All Material provided in the Kit to perform the test
-Recommended for administration by qualified healthcare workers
-Storage at Room Temperature (2-30C).
-Shelf life: 24 months
Cat No : RK081-25. Ulta Covid-19 Ag test is a rapid Immunochromatographic assey for the qualitative detection of specific antigens to SAR-COV-2 present in human nasopharynx.
CAT No : RK055-25. STANDARD Q COVID-19 Ag is a rapid Immunochromatographic assay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx.
Qualitatively detects specific antigens to SARS-CoV-2 present in Human Nasopharynx.
The test should be used as an aid in early diagnosis of symptomatic cases in healthcare setting having ILI.
Validated by ICMR & AIIMS
Sensitivity of 84.38 % & Specificity of 100%
Sample Type- Human Nasopharyngeal swab (No other sample recommended)
Results in 15-30 mins
Cat No: 41FK10. Panbio COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of SARS-CoV-2 antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. Panbio COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of SARS-CoV-2 infection.
Cat. No : F-NCOV-01G. STANDARD F COVID-19 Ag FIA is the fl uorescent immunoassay for the qualitative detection of specific nucleoprotein antigens to SARS-CoV-2 present in human nasopharynx. STANDARD F COVID-19 Ag FIA should be used with the STANDARD F Analyzers manufactured by SD BIOSENSOR. This test is for in vitro professional diagnostic use and intended as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms with SARS-CoV-2 infection.
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing.
1.Easy to collect samples simple operation without professional equipment.
2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy.
4.Suitable for large-scale rapid screening.
Shelf life: 24 Months
Test Result time: 10 Mins
Packing: 25 Pieces per Box
5950 Influenza Covid 19 Ag Triple Suppliers
Short on time? Let Influenza Covid 19 Ag Triple sellers contact you.
